AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
RELATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION TO PRESENCE AND SEVERITY OF ATHEROSCLEROTIC LESIONS IN HUMAN CORONARY-ARTERIES
Authors: KIENAST J PADRO T STEINS M LI CX SCHMID KW HAMMEL D SCHELD HH VANDELOO JCW
Citation: J. Kienast et al., RELATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR EXPRESSION TO PRESENCE AND SEVERITY OF ATHEROSCLEROTIC LESIONS IN HUMAN CORONARY-ARTERIES, Thrombosis and haemostasis, 79(3), 1998, pp. 579-586
INFLAMMATORY MEDIATORS IN BRONCHOALVEOLAR LAVAGE FLUID AND PLASMA IN LEUKOCYTOPENIC PATIENTS WITH SEPTIC SHOCK-INDUCED ACUTE RESPIRATORY-DISTRESS SYNDROME
Authors: KIEHL MG OSTERMANN H THOMAS M MULLER C CASSENS U KIENAST J
Citation: Mg. Kiehl et al., INFLAMMATORY MEDIATORS IN BRONCHOALVEOLAR LAVAGE FLUID AND PLASMA IN LEUKOCYTOPENIC PATIENTS WITH SEPTIC SHOCK-INDUCED ACUTE RESPIRATORY-DISTRESS SYNDROME, Critical care medicine, 26(7), 1998, pp. 1194-1199
MANAGEMENT STRATEGIES AND DETERMINANTS OF OUTCOME IN ACUTE MAJOR PULMONARY-EMBOLISM - RESULTS OF A MULTICENTER REGISTRY
Authors: KASPER W KONSTANTINIDES S GEIBEL A OLSCHEWSKI M HEINRICH F GROSSER KD RAUBER K IVERSEN S REDECKER M KIENAST J
Citation: W. Kasper et al., MANAGEMENT STRATEGIES AND DETERMINANTS OF OUTCOME IN ACUTE MAJOR PULMONARY-EMBOLISM - RESULTS OF A MULTICENTER REGISTRY, Journal of the American College of Cardiology, 30(5), 1997, pp. 1165-1171
NITRIC-OXIDE SYNTHASE INHIBITION BY L-NAME IN LEUKOCYTOPENIC PATIENTSWITH SEVERE SEPTIC SHOCK
Authors: KIEHL MG OSTERMANN H MEYER J KIENAST J
Citation: Mg. Kiehl et al., NITRIC-OXIDE SYNTHASE INHIBITION BY L-NAME IN LEUKOCYTOPENIC PATIENTSWITH SEVERE SEPTIC SHOCK, Intensive care medicine, 23(5), 1997, pp. 561-566
PROCEDURE AND CRITERIA FOR EVALUATION AND STANDARDIZATION OF HEMOSTASIS TESTS AS SHOWN FOR FIBRINOGEN MEASUREMENT
Authors: DATI F DZIUB S KIENAST J MORITZ B MULLERBERGHAUS G OSTERMANN H SPANUTH E WEINSTOCK N WITT P
Citation: F. Dati et al., PROCEDURE AND CRITERIA FOR EVALUATION AND STANDARDIZATION OF HEMOSTASIS TESTS AS SHOWN FOR FIBRINOGEN MEASUREMENT, Thrombosis and haemostasis, 1997, pp. 1794-1794
QUANTITATIVE-ANALYSIS OF UROKINASE RECEPTOR IN DIFFERENT TYPES OF ATHEROSCLEROTIC LESIONS IN HUMAN AORTA
Authors: PADRO T STEINS M MESTERS R SCHWANEN C KIENAST J
Citation: T. Padro et al., QUANTITATIVE-ANALYSIS OF UROKINASE RECEPTOR IN DIFFERENT TYPES OF ATHEROSCLEROTIC LESIONS IN HUMAN AORTA, Thrombosis and haemostasis, 1997, pp. 2318-2318
EFFICACY AND KINETICS OF BONE-MARROW PROCESSING AND ENRICHMENT OF HEMATOPOIETIC PROGENITOR CELLS (HPC) BY A LARGE-VOLUME APHERESIS PROCEDURE
Authors: CASSENS U OSTKAMPOSTERMANN P GARRITSEN H KELSCH R OSTERMANN H KIENAST J KIEHL M BUECHNER T VANDELOO J JUERGENS H SIBROWSKI W
Citation: U. Cassens et al., EFFICACY AND KINETICS OF BONE-MARROW PROCESSING AND ENRICHMENT OF HEMATOPOIETIC PROGENITOR CELLS (HPC) BY A LARGE-VOLUME APHERESIS PROCEDURE, Bone marrow transplantation, 19(8), 1997, pp. 835-840
RECIPROCAL CHANGES IN CIRCULATING INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR DURING EVOLVING SEPSIS IN LEUKOCYTOPENIC PATIENTS
Authors: OSTERMANN H KRATZALBERS K MESTERS RM KIEHL M KIENAST J
Citation: H. Ostermann et al., RECIPROCAL CHANGES IN CIRCULATING INTERLEUKIN-6 AND ITS SOLUBLE RECEPTOR DURING EVOLVING SEPSIS IN LEUKOCYTOPENIC PATIENTS, The Journal of infectious diseases, 176(3), 1997, pp. 825-828
RESUMING ANTICOAGULANT-THERAPY WITH MARCU MAR IN PATIENTS WITH HEART-VALVE REPLACEMENTS FOLLOWING INTRACEREBRAL BLEEDING (STROKE, SAB, SUBDURAL-HEMATOMA)
Authors: KIENAST J RINGELSTEIN EB BORGGREFE M
Citation: J. Kienast et al., RESUMING ANTICOAGULANT-THERAPY WITH MARCU MAR IN PATIENTS WITH HEART-VALVE REPLACEMENTS FOLLOWING INTRACEREBRAL BLEEDING (STROKE, SAB, SUBDURAL-HEMATOMA), Der Internist, 38(1), 1997, pp. 83-85
INFLAMMATORY MEDIATORS IN BAL FLUID AS MARKERS OF EVOLVING PNEUMONIA IN LEUKOCYTOPENIC PATIENTS
Authors: KIEHL MG OSTERMANN H THOMAS M BIRKFELLNER T KIENAST J
Citation: Mg. Kiehl et al., INFLAMMATORY MEDIATORS IN BAL FLUID AS MARKERS OF EVOLVING PNEUMONIA IN LEUKOCYTOPENIC PATIENTS, Chest, 112(5), 1997, pp. 1214-1220
ASSOCIATION BETWEEN THROMBOLYTIC TREATMENT AND THE PROGNOSIS OF HEMODYNAMICALLY STABLE PATIENTS WITH MAJOR PULMONARY-EMBOLISM - RESULTS OF A MULTICENTER REGISTRY
Authors: KONSTANTINIDES S GEIBEL A OLSCHEWSKI M HEINRICH F GROSSER K RAUBER K IVERSEN S REDECKER M KIENAST J JUST H KASPER W
Citation: S. Konstantinides et al., ASSOCIATION BETWEEN THROMBOLYTIC TREATMENT AND THE PROGNOSIS OF HEMODYNAMICALLY STABLE PATIENTS WITH MAJOR PULMONARY-EMBOLISM - RESULTS OF A MULTICENTER REGISTRY, Circulation, 96(3), 1997, pp. 882-888
COMPARATIVE-ANALYSIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 EXPRESSION IN DIFFERENT TYPES OF ATHEROSCLEROTIC LESIONS IN CORONARY-ARTERIES FROM HUMAN HEART EXPLANTS
Authors: PADRO T STEINS M LI CX MESTERS RM HAMMEL D SCHELD HH KIENAST J
Citation: T. Padro et al., COMPARATIVE-ANALYSIS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 EXPRESSION IN DIFFERENT TYPES OF ATHEROSCLEROTIC LESIONS IN CORONARY-ARTERIES FROM HUMAN HEART EXPLANTS, Cardiovascular Research, 36(1), 1997, pp. 28-36
INFLAMMATORY MEDIATORS IN THE BRONCHOALVEOLAR LAVAGE FLUID IN LEUKOCYTOPENIC PATIENTS WITH FEVER
Authors: KIEHL MG OSTERMANN H BIRKFELLNER T BUECHNER T KIENAST J
Citation: Mg. Kiehl et al., INFLAMMATORY MEDIATORS IN THE BRONCHOALVEOLAR LAVAGE FLUID IN LEUKOCYTOPENIC PATIENTS WITH FEVER, Blood, 90(10), 1997, pp. 2939-2939
LOW-PROTEIN-C LEVELS PREDICT OUTCOME IN NEUTROPENIC PATIENTS WITH SEPSIS
Authors: MESTERS RM HARTMAN D YAN B KIENAST J
Citation: Rm. Mesters et al., LOW-PROTEIN-C LEVELS PREDICT OUTCOME IN NEUTROPENIC PATIENTS WITH SEPSIS, Blood, 90(10), 1997, pp. 3191-3191
DOSE-INTENSIFIED ANTITHYMOCYTE GLOBULIN (ATG) IN STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW OR BLOOD STEM-CELL TRANSPLANTATION
Authors: KIENAST J IPPOLITI C MEHRA R UENO N CHAMPLIN R KHOURI I GIRALT S GAJEWSKI J CLAXTON D ANDERLINI P ANDERSSON B PRZEPIORKA D
Citation: J. Kienast et al., DOSE-INTENSIFIED ANTITHYMOCYTE GLOBULIN (ATG) IN STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER ALLOGENEIC MARROW OR BLOOD STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 457-457
ANTITHROMBIN-III AND FIBRINOGEN AS PREDICTORS OF CARDIAC EVENTS IN PATIENTS WITH ANGINA-PECTORIS
Authors: THOMPSON SG FECHTRUP C SQUIRE E HEYSE U BREITHARDT G VANDELOO JCW KIENAST J
Citation: Sg. Thompson et al., ANTITHROMBIN-III AND FIBRINOGEN AS PREDICTORS OF CARDIAC EVENTS IN PATIENTS WITH ANGINA-PECTORIS, Arteriosclerosis, thrombosis, and vascular biology, 16(3), 1996, pp. 357-362
INCREASE OF PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS PREDICTS OUTCOME OF LEUKOCYTOPENIC PATIENTS WITH SEPSIS
Authors: MESTERS RM FLORKE N OSTERMANN H KIENAST J
Citation: Rm. Mesters et al., INCREASE OF PLASMINOGEN-ACTIVATOR INHIBITOR LEVELS PREDICTS OUTCOME OF LEUKOCYTOPENIC PATIENTS WITH SEPSIS, Thrombosis and haemostasis, 75(6), 1996, pp. 902-907
SEVERE HEPATOBILIARY COMPLICATION IN A PATIENT WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID
Authors: SINDERMANN J FOERSTER EC KIENAST J
Citation: J. Sindermann et al., SEVERE HEPATOBILIARY COMPLICATION IN A PATIENT WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITH ALL-TRANS-RETINOIC ACID, Acta oncologica, 35(4), 1996, pp. 499-501
VOLUME-CONTROLLED VERSUS BIPHASIC POSITIVE AIRWAY PRESSURE VENTILATION IN LEUKOPENIC PATIENTS WITH SEVERE RESPIRATORY-FAILURE
Authors: KIEHL M SCHIELE C STENZINGER W KIENAST J
Citation: M. Kiehl et al., VOLUME-CONTROLLED VERSUS BIPHASIC POSITIVE AIRWAY PRESSURE VENTILATION IN LEUKOPENIC PATIENTS WITH SEVERE RESPIRATORY-FAILURE, Critical care medicine, 24(5), 1996, pp. 780-784
FAVORABLE EFFECT OF THROMBOLYTIC TREATMENT ON THE CLINICAL OUTCOME OFHEMODYNAMICALLY STABLE PATIENTS WITH ACUTE MASSIVE PULMONARY-EMBOLISM- THE MANAGEMENT AND PROGNOSIS OF PULMONARY-EMBOLISM REGISTRY (MAPPET)
Authors: KONSTANTINIDES S KASPER W KIENAST J GEIBEL A OLSCHEWSKI M REDECKER M RAUBER K HEINRICH F
Citation: S. Konstantinides et al., FAVORABLE EFFECT OF THROMBOLYTIC TREATMENT ON THE CLINICAL OUTCOME OFHEMODYNAMICALLY STABLE PATIENTS WITH ACUTE MASSIVE PULMONARY-EMBOLISM- THE MANAGEMENT AND PROGNOSIS OF PULMONARY-EMBOLISM REGISTRY (MAPPET), Circulation, 94(8), 1996, pp. 3343-3343
PREDICTORS OF IN-HOSPITAL MORTALITY IN PATIENTS WITH ACUTE MASSIVE PULMONARY-EMBOLISM - RESULTS OF THE MANAGEMENT AND PROGNOSIS OF PULMONARY-EMBOLISM REGISTRY (MAPPET)
Authors: KONSTANTINIDES S GEIBEL A KASPER W OLSCHEWSKI M KIENAST J IVERSEN S GROSSER KD
Citation: S. Konstantinides et al., PREDICTORS OF IN-HOSPITAL MORTALITY IN PATIENTS WITH ACUTE MASSIVE PULMONARY-EMBOLISM - RESULTS OF THE MANAGEMENT AND PROGNOSIS OF PULMONARY-EMBOLISM REGISTRY (MAPPET), Circulation, 94(8), 1996, pp. 3344-3344
FACTOR VIIA AND ANTITHROMBIN-III ACTIVITY DURING SEVERE SEPSIS AND SEPTIC SHOCK IN NEUTROPENIC PATIENTS
Authors: MESTERS RM MANNUCCI PM COPPOLA R KELLER T OSTERMANN H KIENAST J
Citation: Rm. Mesters et al., FACTOR VIIA AND ANTITHROMBIN-III ACTIVITY DURING SEVERE SEPSIS AND SEPTIC SHOCK IN NEUTROPENIC PATIENTS, Blood, 88(3), 1996, pp. 881-886
CONSIDERATIONS ABOUT PLASMA-FIBRINOGEN CONCENTRATION AND THE CARDIOVASCULAR RISK - COMBINED EVIDENCE FROM THE GRIPS AND ECAT STUDIES
Authors: CREMER P NAGEL D SEIDEL D VANDELOO JCW KIENAST J
Citation: P. Cremer et al., CONSIDERATIONS ABOUT PLASMA-FIBRINOGEN CONCENTRATION AND THE CARDIOVASCULAR RISK - COMBINED EVIDENCE FROM THE GRIPS AND ECAT STUDIES, The American journal of cardiology, 78(3), 1996, pp. 380-381
QUANTIFICATION OF PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS IN THE AORTIC VESSEL WALL IN RELATION TO THE PRESENCE AND SEVERITY OF ATHEROSCLEROTIC DISEASE
Authors: PADRO T EMEIS JJ STEINS M SCHMID KW KIENAST J
Citation: T. Padro et al., QUANTIFICATION OF PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS IN THE AORTIC VESSEL WALL IN RELATION TO THE PRESENCE AND SEVERITY OF ATHEROSCLEROTIC DISEASE, Arteriosclerosis, thrombosis, and vascular biology, 15(7), 1995, pp. 893-902
COAGULATION AND FIBRINOLYSIS - FROM PLASMA TO VESSEL WALL
Authors: KIENAST J
Citation: J. Kienast, COAGULATION AND FIBRINOLYSIS - FROM PLASMA TO VESSEL WALL, Cerebrovascular diseases, 5(2), 1995, pp. 89-92
Risultati: 1-25 | 26-43